Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 1

Review

Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)

       
Total article views   HTML views PDF downloads Totals
7,992 Dovepress* 7,992+ 1,997 9,989
Totals 7,992 1,997 9,989
*Since 7 March 2008
+Since July 2016

View citations on Google Scholar